GlobeNewsWire
11 Mar 2026, 16:12 UTC · 28w ago
Verdict
Headline takes no side. We score CDRE −0.80 across three claims — strongly bearish.
−0.80strongly bearish
More negative than 86% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Cadre Holdings reported Q4 2025 revenue of $167.2 million and EPS of $0.27, both significantly missing analyst expectations of $184–$186 million and $0.40 respectively.
So whatMaterial misses on both top and bottom lines typically trigger immediate downward revisions of valuation and stock price.
More negative than 95% of claims this week
Cadre's full-year 2025 revenue of $610.3 million failed to meet the company's own previously reaffirmed guidance range of $624 million to $630 million.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 91% of claims this week
Law firm Johnson Fistel, PLLP is investigating Cadre Holdings for potential federal securities law violations following the stock's price drop on March 11, 2026.
More negative than 79% of claims this week
Which stocks this story touches
More negative than 86% of ticker scores this week
The company missed revenue and EPS expectations and is currently under investigation for potential securities law violations.
More negative than 80% of ticker scores this week
The company is being investigated by a law firm on behalf of investors who suffered losses.
More negative than 80% of ticker scores this week
The company is the subject of an investigation into potential securities law violations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1h ago
−34.4%
Price agrees with the score
$26.68 vs $40.69 close before publication (Mar 10) · not market-adjusted
CDRE chart →
